26 February 2026
26 February 2026
Quantum Surgical has developed the Epione robotic platform for early-stage tumour interventions.
Vivtex is set to receive research funding, upfront payments, milestone payments up to $2.1bn, and tiered royalties.
The Synchfix EVT device builds on the previous Synchfix platform and introduces design improvements to minimise procedural complexity.
VO659 aims to address nine polyglutamine disorders, including HD, SCA3 and SCA1.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
